We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
71 hedge funds and large institutions have $74.5M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,412% more call options, than puts
Call options by funds: $257K | Put options by funds: $17K
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
5% less funds holding
Funds holding: 75 → 71 (-4)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
29% less capital invested
Capital invested by funds: $105M → $74.5M (-$30.1M)
Holders
71
Holders Change
-4
Holders Change %
-5.33%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
26
Reduced
19
Closed
15
Calls
$257K
Puts
$17K
Net Calls
+$240K
Net Calls Change
+$158K
Top Buyers
| 1 |
BlackRock
New York
|
+$1.74M |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$783K |
| 3 |
Renaissance Technologies
New York
|
+$444K |
| 4 |
Bank of New York Mellon
New York
|
+$406K |
| 5 |
State Street
Boston,
Massachusetts
|
+$402K |
Top Sellers
| 1 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$1.27M |
| 2 |
Morgan Stanley
New York
|
-$253K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$253K |
| 4 |
JP Morgan Chase
New York
|
-$196K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$176K |
